TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19906800

Group type: EXPERIMENTAL
Intervention: 600 mg Ca/d
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: 1200 mg Ca/d
Number of subjects: 323

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study: 17140871

Group type: EXPERIMENTAL
Intervention: High-impact exercise regimen (supervised, progressive, three times per week)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-impact exercise regimen (most active exercisers >66 sessions)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-impact exercise regimen
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 120
Study: 15390196

Group type: EXPERIMENTAL
Intervention: PSSD (computerized pressure‐specific sensory device)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: SWM (Semmes Weinstein Monofilament)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: PSSD
Number of subjects: 41

Group type: COMPARATOR
Intervention: SWM and PSSD
Number of subjects: 41
Study: 12628633

Group type: EXPERIMENTAL
Intervention: group CBT (n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: psychological placebo intervention (i.e., emotional disclosure [ED]; n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: no‐treatment control condition (n = 10)
Number of subjects: 30
Study: 9658756

Group type: EXPERIMENTAL
Intervention: SYNPEP HCV‐EIA II
Number of subjects: 0
Study: 7632029

Group type: EXPERIMENTAL
Intervention: diltiazem-trimetazidine (60 mg/24 h)
Number of subjects: 67

Group type: COMPARATOR
Intervention: diltiazem-placebo
Number of subjects: 67
Study: 2792112

Group type: EXPERIMENTAL
Intervention: 30 mg nicardipine
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 40 mg nicardipine
Number of subjects: 46
Study: 339788

Group type: EXPERIMENTAL
Intervention: Albuterol aerosol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isoproterenol aerosol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29153546

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation for 48 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 30074327

Group type: EXPERIMENTAL
Intervention: 15 μg of clonidine with hyperbaric bupivacaine (BC15 group)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 30 μg of clonidine with hyperbaric bupivacaine (BC30 group)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 60 μg of clonidine with hyperbaric bupivacaine (BC60 group)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine alone (Control not explicitly mentioned)
Number of subjects: 105
Study: 25682602

Group type: EXPERIMENTAL
Intervention: Prednisone 1 mg/kg/day for grade IIa manifestations
Number of subjects: 164

Group type: COMPARATOR
Intervention: Prednisone 0.5 mg/kg/day for grade IIa manifestations
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Prednisone 2 mg/kg/day for grade IIb or higher manifestations
Number of subjects: 164

Group type: COMPARATOR
Intervention: Prednisone 1 mg/kg/day for grade IIb or higher manifestations
Number of subjects: 164
Study: 23947388

Group type: EXPERIMENTAL
Intervention: Educational hand washing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 20454943

Group type: EXPERIMENTAL
Intervention: Standard-dose ganciclovir (5 mg/kg twice daily for 1 week)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low-dose ganciclovir (5 mg/kg twice daily for 1 week)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Standard-dose ganciclovir
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low-dose ganciclovir
Number of subjects: 68
Study: 18208428

Group type: EXPERIMENTAL
Intervention: The '11' exercise program, a 15-min warm-up for football training, used over an 8-month season.
Number of subjects: 2092

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 2092
Study: 15230706

Group type: EXPERIMENTAL
Intervention: Transcortical approach
Number of subjects: 80

Group type: COMPARATOR
Intervention: Transsylvian approach
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 80
Study: 12019196

Group type: EXPERIMENTAL
Intervention: Rofecoxib (125 mg, 100 micro Ci) in healthy subjects
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Rofecoxib (142 mg, 100 micro Ci) in cholecystectomy patients
Number of subjects: 2
Study: 9808550

Group type: EXPERIMENTAL
Intervention: IFN plus PUVA
Number of subjects: 82

Group type: COMPARATOR
Intervention: IFN plus acitretin
Number of subjects: 82
Study: 7621843

Group type: EXPERIMENTAL
Intervention: Bambuterol 20 mg nocte
Number of subjects: 152

Group type: COMPARATOR
Intervention: Salbutamol CR 8 mg b.i.d.
Number of subjects: 152
Study: 2930745

Group type: EXPERIMENTAL
Intervention: Suburethral sling
Number of subjects: 20

Group type: COMPARATOR
Intervention: Stamey endoscopic bladder neck suspension
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sling procedure
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stamey procedure
Number of subjects: 20
Study: 798127

Group type: EXPERIMENTAL
Intervention: Elantrine
Number of subjects: 0
Study: 31633738

Group type: EXPERIMENTAL
Intervention: Tailored, Family-Involved Hospital Elder Life Program (t-HELP)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 281
Study: 31238421

Group type: EXPERIMENTAL
Intervention: Ranibizumab only (RBZ group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ranibizumab with UWFFA-guided laser (RBZ + TRP group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 32
Study: 28117378

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the medial prefrontal cortex (mPFC) in females
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo tDCS over the medial prefrontal cortex (mPFC) in females
Number of subjects: 32

Group type: COMPARATOR
Intervention: Anodal tDCS over the vertex in females
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the medial prefrontal cortex (mPFC) in males
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo tDCS over the vertex in males
Number of subjects: 32
Study: 24947812

Group type: EXPERIMENTAL
Intervention: Isometric training with vibration (ST+VT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isometric training without vibration (ST)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 24
Study: 23154577

Group type: EXPERIMENTAL
Intervention: Postprandial exercise (walking on a motorized treadmill at ca. 50%V(·)o(2)max for 30 min) after glucose intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postprandial exercise (walking on a motorized treadmill at ca. 50%V(·)o(2)max for 30 min) after glucose with OFTT cream intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postprandial exercise
Number of subjects: 0
Study: 21632504

Group type: EXPERIMENTAL
Intervention: Id vaccine (Id-KLH + GM-CSF)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control (KLH + GM-CSF)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: IgM-Id vaccine
Number of subjects: 177

Group type: COMPARATOR
Intervention: Isotype-matched control
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: IgG-Id vaccine
Number of subjects: 177
Study: 19098687

Group type: EXPERIMENTAL
Intervention: 25 mg/d of dehydroepiandrosterone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17101607

Group type: EXPERIMENTAL
Intervention: 1.2 g amino acids, 1.2 g glycerol, and 0.5 g fat emulsion/kg/day (approximately 15 kcal/kg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1.2 g amino acids, 1.5 g dextrose, and 0.5 g fat emulsion/kg/day (approximately 15 kcal/kg/day)
Number of subjects: 30
Study: 15551695

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11694202

Group type: EXPERIMENTAL
Intervention: Cessation trial participants
Number of subjects: 401

Group type: COMPARATOR
Intervention: General population chewers
Number of subjects: 401
Study: 9203190

Group type: EXPERIMENTAL
Intervention: rHuEPO 50 U/kg once a week (group 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: rHuEPO 150 U/kg three times a week (group 2)
Number of subjects: 20
Study: 7929736

Group type: EXPERIMENTAL
Intervention: Ultrasonic texture score
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Ultrasonic testicular volume
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Ultrasonic volume
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Sperm count
Number of subjects: 95
Study: 3602843

Group type: EXPERIMENTAL
Intervention: Ivermectin (100, 150, and 200 mcg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 0
Study: 29468854

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 27571249

Group type: EXPERIMENTAL
Intervention: Metformin 2000 mg daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 24598116

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 74
Study: 22688848

Group type: EXPERIMENTAL
Intervention: Community-based intervention with five interrelated components designed to reduce underage access to alcohol.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High intensity implementation of underage drinking law enforcement.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Enhanced enforcement of underage drinking laws.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned).
Number of subjects: 36
Study: 20006290

Group type: EXPERIMENTAL
Intervention: Anma therapy (40-min session)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Rest intervention (40-min session)
Number of subjects: 15
Study: 18200453

Group type: EXPERIMENTAL
Intervention: Probatory CPAP therapy with follow-up examination
Number of subjects: 249

Group type: COMPARATOR
Intervention: Immediate prescription of CPAP device
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Probatory CPAP therapy
Number of subjects: 249
Study: 15239144

Group type: EXPERIMENTAL
Intervention: High observed adenoma detection rates at surveillance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low observed colorectal cancer incidence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colorectal cancer screening strategies focusing on adenoma detection
Number of subjects: 0
Study: 12575587

Group type: EXPERIMENTAL
Intervention: Music therapy combined with anti-tumor drugs
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 162
Study: 9099469

Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dispersible Madopar
Number of subjects: 12
Study: 8555639

Group type: EXPERIMENTAL
Intervention: Pharmacomechanical thrombolysis
Number of subjects: 146

Group type: COMPARATOR
Intervention: Surgical thrombectomy
Number of subjects: 146
Study: 3475036

Group type: EXPERIMENTAL
Intervention: Enoxacin 600 mg, single dose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enoxacin 400 mg, single dose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enoxacin 400 mg every 12 h, four doses
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All enoxacin doses
Number of subjects: 20
Study: 30597504

Group type: EXPERIMENTAL
Intervention: 2-g oral TXA 2 hours pre-operatively followed by 1-g oral TXA 3 hours post-operatively (group B)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 2-g oral TXA followed by 1-g oral TXA 3 and 7 hours post-operatively (group C)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 2-g oral TXA followed by 1-g oral TXA 3, 7 and 11 hours post-operatively (group D)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 2-g oral TXA followed by 1-g oral TXA 3, 7, 11 and 15 hours post-operatively (group E)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Matching placebo (control group A)
Number of subjects: 240
Study: 30390675

Group type: EXPERIMENTAL
Intervention: Medicinal plants used by local community
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Traditional medicinal plant knowledge
Number of subjects: 78
Study: 27005659

Group type: EXPERIMENTAL
Intervention: Folic acid fortified flour
Number of subjects: 16648

Group type: COMPARATOR
Intervention: Ordinary flour (Control)
Number of subjects: 16648
Study: 25226009

Group type: EXPERIMENTAL
Intervention: Clindamycin-BP 3.75%
Number of subjects: 498

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 498
Study: 22565161

Group type: EXPERIMENTAL
Intervention: Once-daily MMX mesalamine 2.4 g/day
Number of subjects: 826

Group type: COMPARATOR
Intervention: Twice-daily delayed-release mesalamine 1.6 g/day
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 826
Study: 19838864

Group type: EXPERIMENTAL
Intervention: Local anesthetic injection (2 ml lidocaine of 1%)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dry needling on trigger points
Number of subjects: 80
Study: 18058494

Group type: EXPERIMENTAL
Intervention: Adalimumab 80 mg at Week 0 and 40 mg every other week from Week 1 to Week 15
Number of subjects: 0
Study: 16343396

Group type: EXPERIMENTAL
Intervention: Tisseel
Number of subjects: 56

Group type: COMPARATOR
Intervention: Non-Tisseel
Number of subjects: 56
Study: 11747061

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation training offered independently of medical treatment
Number of subjects: 0
Study: 9205767

Group type: EXPERIMENTAL
Intervention: ebrotidine 400 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ebrotidine 800 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 7970506

Group type: EXPERIMENTAL
Intervention: Taxol 135 mg/m2
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Taxol 175 mg/m2
Number of subjects: 471

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 471
Study: 3620002

Group type: EXPERIMENTAL
Intervention: Beck depression scale (1, 2, or 3 occasions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Zung depression scale (1, 2, or 3 occasions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Initial test administration (Beck and Zung scales)
Number of subjects: 60
Study: 30508645

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D levels categorized in four groups: <25.0, 25.0-49.9, 50.0-74.9, and ≥75.0 nmol/L (highest group as reference)
Number of subjects: 5110

Group type: EXPERIMENTAL
Intervention: Participants with arthritis (n=1732)
Number of subjects: 5110

Group type: EXPERIMENTAL
Intervention: Participants with depression (n=528)
Number of subjects: 5110
Study: 28287413

Group type: EXPERIMENTAL
Intervention: Fructose Supplement (FS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glucose Supplement (GS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fructose Control (FC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glucose Control (GC)
Number of subjects: 10
Study: 24853650

Group type: EXPERIMENTAL
Intervention: MST
Number of subjects: 20

Group type: COMPARATOR
Intervention: ECT
Number of subjects: 20
Study: 24483106

Group type: EXPERIMENTAL
Intervention: Shenling Fuzheng Capsule (SFC) or Qingdu Capsule (QC)
Number of subjects: 220

Group type: COMPARATOR
Intervention: SFC or QC combined with highly active antiretroviral agents
Number of subjects: 220
Study: 22051498

Group type: EXPERIMENTAL
Intervention: High fluoride intake and heavy force
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low fluoride intake and heavy force
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High fluoride intake and light force
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low fluoride intake and light force
Number of subjects: 48
Study: 19903376

Group type: EXPERIMENTAL
Intervention: 100 mg/day of aspirin
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 300 mg/day of aspirin
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 17011743

Group type: EXPERIMENTAL
Intervention: Semantic (animal) fluency task
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Letter (S and P) fluency task
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Combination of semantic fluency and narrative recall
Number of subjects: 153
Study: 15491387

Group type: EXPERIMENTAL
Intervention: Combined therapy of enalapril and losartan (Group A)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 9
Study: 11080322

Group type: EXPERIMENTAL
Intervention: Thermoluminescent dosimeter (TLD) measurements of radiation dose to the skin and whole body over the lead apron.
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Thermoluminescent dosimeter (TLD) measurements of radiation dose to the whole body under the lead apron.
Number of subjects: 235
Study: 9282076

Group type: EXPERIMENTAL
Intervention: Standard Care Plan Guide
Number of subjects: 1827
Study: 8342744

Group type: EXPERIMENTAL
Intervention: Atropine (10 micrograms/kg i.v.) and droperidol (75 micrograms/kg i.v.) before the beginning of surgery (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Atropine (10 micrograms/kg i.v.) before the beginning, droperidol (75 micrograms/kg i.v.) after completion of surgery (Group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: No atropine, droperidol (75 micrograms/kg i.v.) before the beginning of surgery (Group C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: No atropine, droperidol (75 micrograms/kg i.v.) after completion of surgery (Group D)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Atropine (10 micrograms/kg i.v.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No atropine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Droperidol (75 micrograms/kg) timing
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Atropine (10 micrograms/kg) prior to surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Atropine (10 micrograms/kg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Younger children (3 to 6 years)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with more than two eye muscles repaired
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Recovery scores
Number of subjects: 100
Study: 25646022

Group type: EXPERIMENTAL
Intervention: Brief behavioral sleep intervention (2 clinical consultations and a follow-up phone call covering sleep hygiene and standardized behavioral strategies)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 61
Study: 30062709

Group type: EXPERIMENTAL
Intervention: Quercetin 1,000 mg/day for 12 weeks
Number of subjects: 78
Study: 27501900

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT (ULDCT) (100 kVp ± 20 and 10 mAs)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Low-dose computed tomography (LDCT) (100 kVp and 60 mAs)
Number of subjects: 133
Study: 24567266

Group type: EXPERIMENTAL
Intervention: Hands-on virtual reality (VR) intervention
Number of subjects: 258

Group type: COMPARATOR
Intervention: Pre-VR intervention (prior to lecture)
Number of subjects: 258
Study: 22405632

Group type: EXPERIMENTAL
Intervention: TARGET (Targeted Left Ventricular Lead Placement)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control (standard unguided CRT)
Number of subjects: 220
Study: 20578205

Group type: EXPERIMENTAL
Intervention: High-protein diet (1.34 g/kg body weight)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional protein diet (0.8 g/kg body weight)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional protein diet
Number of subjects: 67
Study: 18385992

Group type: COMPARATOR
Intervention: Stented group (21 patients)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Unstented group (22 patients)
Number of subjects: 43
Study: 16404866

Group type: EXPERIMENTAL
Intervention: ARTRA (500 mg glucosamine hydrochloride + 500 mg chondroitine sulphate) taken 1 tablet 2 times a day for the first month, then 1 tablet a day for the following 5 months, along with diclofenac sodium 50 mg 2 times a day with gradual decrease as pain decreased.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diclofenac sodium 50 mg twice a day for 6 months (control group).
Number of subjects: 90
Study: 12892444

Group type: EXPERIMENTAL
Intervention: Local anesthetic with N2O:O2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local anesthetic only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gow‐Gates/standard block, standard block/Vazirani‐Akinosi, Gow‐Gates/Vazirani‐Akinosi
Number of subjects: 60
Study: 10470627

Group type: EXPERIMENTAL
Intervention: Propofol 2.0 mg/kg i.v. followed by continuous infusion of 170 micrograms kg‐1 min‐1 (with additional 0.5 mg/kg if needed)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane 5% inhalation
Number of subjects: 60
Study: 8934168

Group type: EXPERIMENTAL
Intervention: Detachable snare
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional polypectomy without detachable snare
Number of subjects: 89
Study: 1989740

Group type: EXPERIMENTAL
Intervention: Promethazine (0.5 mg.kg‐1 IV + 0.5 mg.kg‐1 IM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Droperidol (0.075 mg.kg‐1 IV + physiological saline, 0.02 ml.kg‐1 IM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Promethazine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Droperidol
Number of subjects: 100
Study: 6137231

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Atropine (0.04 mg/kg)
Number of subjects: 6
Study: 28902116

Group type: EXPERIMENTAL
Intervention: Preconditioning exercise with WBV (40 Hz, 2 mm)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Preconditioning exercise without WBV
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both conditions (WBV and no WBV)
Number of subjects: 14